Augmentation of thyrotropin-induced iodide uptake in FRTL-5 cells by immunoglobulins containing blocking thyrotropin-receptor antibodies under NaCl-depleted conditions. 1995

R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
Department of Nuclear Medicine, Kyoto University School of Medicine, Japan.

We have found recently that Graves' immunoglobulins (Igs) are more active under NaCl-free conditions to increase iodide uptake in FRTL-5 thyroid cells. The present study was designed to examine the effect of blocking-type thyrotropin (TSH)-receptor antibodies (TR-abs) in the same assay. FRTL-5 cells were incubated with crude Ig fractions from 13 patients with primary hypothyroidism having blocking TR-abs and 100 mU/l bovine TSH in NaCl-free Hanks' balanced salt solution (HBSS) supplemented with 274 mmol/l sucrose (HBSS(-)-sucrose) to keep isotonicity for 3 days, followed by the determination of 60 min of 125I uptake in the cells. Thyrotropin alone increased the uptake to 3.3- to 5.2-fold of the basal. When the highest concentration (250 ml serum equivalent (eq.)/l) of the Ig was used, the TSH-stimulated 125I uptake was decreased to 0-42% in 11 of the 13 cases. When the lower concentrations (0.4-50 ml serum eq./l) were used, however, 125I uptake was enhanced (1.4- to 11.4-fold) unexpectedly in all 13 cases. Such an enhancement was specific to blocking TR-abs, because the effect was duplicated by the purified IgG but not by Igs from 10 healthy control subjects or from three TR-ab-negative hypothyroid patients. When Graves' Igs, instead of TSH, were used as a stimulator, the similar stimulatory effect of the Ig with blocking activity was observed on the 125I uptake induced by three Graves' Igs but not on the response to one Graves' Ig. These Igs alone displayed no stimulating activity. When isotonic 5H medium was used instead of HBSS(-)-sucrose, effects of these 13 Igs were only inhibitory on the TSH-stimulated 125I uptake.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007454 Iodides Inorganic binary compounds of iodine or the I- ion. Iodide
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011989 Receptors, Thyrotropin Cell surface proteins that bind pituitary THYROTROPIN (also named thyroid stimulating hormone or TSH) and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease (THYROIDITIS, AUTOIMMUNE). Receptors, Thyroid Stimulating Hormone,TSH Receptors,Thyroid Stimulating Hormone Receptors,Thyrotropin Receptors,LATS Receptors,Receptor, LATS Immunoglobulins,Receptors, LATS,Receptors, Long-Acting Thyroid Stimulator,Receptors, TSH,TSH Receptor,Thyroid Stimulating Hormone Receptor,Thyrotropin Receptor,Receptor, TSH,Receptor, Thyrotropin,Receptors, Long Acting Thyroid Stimulator
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
April 1984, Endocrinology,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
November 1992, Acta endocrinologica,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
February 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
June 1986, Endocrinology,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
December 1986, Biochemical and biophysical research communications,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
September 2005, Molecular nutrition & food research,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
October 1997, Thyroid : official journal of the American Thyroid Association,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
February 1992, Biochemical and biophysical research communications,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
February 2001, European journal of endocrinology,
R Takeuchi, and K Kasagi, and A Hidaka, and S Miyamoto, and T Misaki, and Y Iida, and J Konishi
October 1991, Molecular and cellular endocrinology,
Copied contents to your clipboard!